Dabur's India sales growth has slowed down sharply from a lofty 19% CAGR over FY06-13 to a mere 7% over FY13-17. FY17 annual report suggests renewed thrust on positioning the company as a Science-based Ayurveda' specialist to bring growth back. However, we see more of the same when we rea..